Performing left atrial appendage occlusion (LAAO) in patients undergoing cardiac surgery may be beneficial even in the absence of preexisting atrial fibrillation (AF), a meta-analysis suggests. Though ...

The potential for left atrial appendage occlusion (LAAO) to provide a clinical benefit relative to lifelong oral anticoagulation in atrial fibrillation (AF) varies based on a patient’s risks of stroke ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. BOSTON — At 3 years, the Amplatzer Amulet device ...

Please provide your email address to receive an email when new articles are posted on . From 2016 to 2019, percutaneous left atrial appendage occlusion procedures for stroke prevention rose and major ...

SAN FRANCISCO — Left atrial appendage occlusion (LAAO) at the time of transcatheter aortic valve replacement (TAVR) using the WATCHMAN 2.5 device (Boston Scientific) is feasible and non-inferior to ...

GENT, Belgium--(BUSINESS WIRE)--FEops today announced that it received authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide™ pre-operative planning of left atrial ...

The odds of complications and early mortality are higher among LAAO recipients with kidney impairment. Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) increase the risks for ...

A medical milestone has been achieved in Deep East Texas as the first Left Atrial Appendage Occlusion (LAAO) procedure utilizing the Boston Scientific Watchman FLX Pro device was successfully ...

The US Food and Drug Administration (FDA) is informing healthcare providers of potential differences in procedural outcomes between men and women undergoing transcatheter left atrial appendage ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is increasing in incidence and ...

NASHUA, N.H., Oct. 14, 2025 /PRNewswire/ -- Conformal Medical, Inc., a medical device company developing next-generation technology for left atrial appendage occlusion (LAAO), today announced the ...